Article
Loss of HMCES is synthetic lethal with APOBEC activity in cancer cells
medRxiv · 2021 · Biayna, J.; Garcia-Cao, I.; Alvarez, M. M.; Salvadores, M.; Espinosa-Carrasco, J.; McCullough, M.; Supek, F.; Stracker, T. H.
Key facts
| Title | Loss of HMCES is synthetic lethal with APOBEC activity in cancer cells |
|---|---|
| First author | Biayna, J.; Garcia-Cao, I.; Alvarez, M. M.; Salvadores, M.; Espinosa-Carrasco, J.; McCullough, M.; Supek, F.; Stracker, T. H. |
| Journal | medRxiv |
| Published | Feb 6, 2021 |
| DOI | 10.1101/2021.02.05.429803 |
| Devices mentioned | BK110039 |
| Product codes mentioned | KIT, MSJ, NDS, NJT, PFT, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1